Global Biopharmaceutical Manufacturing Market Report 2016 - 2021

Imarc www.imarcgroup.com

Consulting Services

Copyright © 2016 International Market Analysis Research & Consulting (IMARC). All Rights Reserved

Global Biopharmaceutical Manufacturing Market

Witnessing a Shift Towards Contract Manufacturing

Organisations

The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report DescriptionAbout IMARC Group Imarc www.imarcgroup.com

Report DescriptionReport Description and Highlights Imarc www.imarcgroup.com

Global Biopharmaceutical Manufacturing Market Witnessing a Shift Towards Contract Manufacturing Organisations

Biopharmaceutical manufacturing is a cost-intensive and time taking process which requires expertise. In order to reduce manufacturing costs, biopharmaceutical companies are outsourcing their manufacturing operations to Contract Manufacturing Organisations (CMOs).

According to IMARC’s study “Global Biopharmaceutical Manufacturing Market Report 2016-2021”, the global biopharmaceutical manufacturing capacity has grown at a CAGR of more than 6% during 2008-2015. Compared to pharmaceutical products which are synthesized chemically, biopharmaceuticals are manufactured from biological sources. However, their development and production is a complex and delicate process involving superior technology and highly skilled work force. The production facilities are also more expensive and require more time to set-up as compared to small molecule drugs. These facilities are also significantly costlier to run and involve long process durations, low yields and expensive raw materials. The global biopharmaceutical manufacturing market is currently being driven by improved technologies and processes, emergence of biosimilars, entry of new players, growing demand for vaccines & biologic drugs worldwide and an increase in the global ageing population.


Browse press release: http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market-report

Currently, biopharmaceuticals represent the fastest developing segment of the global pharmaceutical market. The increasing popularity of biopharmaceuticals and high returns have led to a number of companies developing and manufacturing them. In most cases biopharmaceuticals are manufactured in-house by innovator companies. This trend, however, is changing and shifting towards contract manufacturing organizations (CMOs). This trend is currently being driven both by significant cost savings and the recognition that contract manufacturing organizations (CMOs) can be more effective, innovative and efficient partners with specific capabilities that can even exceed those available in-house.

IMARC’s report provides a detailed analysis of the biopharmaceutical manufacturing market. The report has segmented the market on the basis of the cell culture used for manufacturing biopharmaceuticals. Findings from the report suggest that mammalian cell culture currently dominates the global biopharmaceutical production. The report has also studied the biopharmaceuticals manufacturing market on the basis of class. The classes covered in the report include – monoclonal antibodies, recombinant proteins, interferons, granulocyte colony-stimulating factor (G-CSF),erythropoietin, recombinant human insulin, vaccines and human growth hormones (HGH).

http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market-report


On the basis of geographical segmentation, the report has covered Asia, Europe and North America. Currently, North America dominates the global biopharmaceuticals manufacturing market accounting for nearly half of the total market share followed by Europe and Asia. Asia, on the other hand, represents the fastest growing market for biopharmaceutical manufacturing. The report has also analysed the competitive landscape of the global biopharmaceutical manufacturing market. Some of the key players covered by the report include – Roche Ltd., Amgen, Novo Nordisk, AbbVie, Sanofi S.A, Johnson & Johnson, Pfizer, Merck & Co., Eli Lilly and Company, and Biogen Idec, Inc.

Enquiry for sample report or more details, click here: http://www.imarcgroup.com/enquiry-form/

http://www.imarcgroup.com/enquiry-form/


Table of Contents

1 Research Methodology and Market Definitions2 Executive Summary3 Global Biopharmaceutical Market: Key Trends3.1 Biopharmaceuticals are Growing Faster than Small Molecule Drugs3.2 Growth of Biosimilars will Push Volumes and Introduce New Players in this Market3.3 A Rich Biopharmaceutical Pipeline will Drive the Capacity Demand in the Coming Years3.4 Increasing Trends in Mergers and Acquisitions will Increase Redundant Capacities3.5 Increasing Focus on Personalized Medicines and High Value Low Volume Markets3.6 Higher Titers will Reduce Capacity Demand3.7 Growth in the Use of Cost Effective Disposable Technologies3.8 Despite Sufficient Global Capacity, Its Uneven Distribution will Continue to Spur Demand4 Global Biopharmaceutical Market: Industry Performance4.1 Current and Historical Sales Trends4.2 Market Breakup by Region4.3 Market Breakup by Expression Systems4.4 Market Breakup by Product Type4.5 Market Outlook5 Regional Biopharmaceutical Market Analysis5.1 United States


5.1.1 Current and Historical Sales Trends5.1.2 Market Outlook5.2 Canada5.2.1 Current and Historical Sales Trends5.2.2 Market Outlook5.3 United Kingdom5.3.1 Current and Historical Sales Trends5.3.2 Market Outlook5.4 Germany5.4.1 Current and Historical Sales Trends5.4.2 Market Outlook5.5 France5.5.1 Current and Historical Sales Trends5.5.2 Market Outlook5.6 Italy5.6.1 Current and Historical Sales Trends5.6.2 Market Outlook5.7 Spain5.7.1 Current and Historical Sales Trends5.7.2 Market Outlook5.8 Russia


5.8.1 Current and Historical Sales Trends5.8.2 Market Outlook5.9 Brazil5.9.1 Current and Historical Sales Trends5.9.2 Market Outlook5.10 Australia5.10.1 Current and Historical Sales Trends5.10.2 Market Outlook6 Global Biopharmaceutical Manufacturing Industry6.1 Current and Historical Manufacturing Capacity Trends6.2 Market Breakup by Region6.2.1 North America6.2.1.1 Current and Historical Manufacturing Capacity Trends6.2.1.2 Market Outlook6.2.2 Europe6.2.2.1 Current and Historical Manufacturing Capacity Trends6.2.2.2 Market Outlook6.2.3 Asia6.2.3.1 Current and Historical Manufacturing Capacity Trends6.2.3.2 Market Outlook6.3 Market Breakup by Cell Culture


6.3.1 Mammalian Cell Culture6.3.1.1 Key Market Drivers6.3.1.2 Current and Historical Sales Trends6.3.1.3 Current and Historical Manufacturing Capacity Trends6.3.1.4 Market Breakup by Region6.3.1.5 Market Breakup by Product Type6.3.1.6 Key Players6.3.1.7 Market Outlook6.3.2 Microbial Cell Culture6.3.2.1 Key Market Drivers6.3.2.2 Current and Historical Sales Trends6.3.2.3 Current and Historical Manufacturing Capacity Trends6.3.2.4 Market Breakup by Product6.3.2.5 Market Breakup by Region6.3.2.6 Key Players6.3.2.7 Market Outlook6.4 Market Breakup by Class6.4.1 Monoclonal Antibodies6.4.1.1 Current and Historical Sales Trends6.4.1.2 Market Outlook6.4.2 Recombinant Proteins


6.4.2.1 Current and Historical Sales Trends6.4.2.2 Market Outlook6.4.3 Interferon6.4.3.1 Current and Historical Sales Trends6.4.3.2 Market Outlook6.4.4 Granulocyte Colony-Stimulating Factor (G-CSF)6.4.4.1 Current and Historical Sales Trends6.4.4.2 Market Outlook6.4.5 Erythropoietin6.4.5.1 Current and Historical Sales Trends6.4.5.2 Market Outlook6.4.6 Recombinant Human Insulin6.4.6.1 Current and Historical Sales Trends6.4.6.2 Market Outlook6.4.7 Vaccines6.4.7.1 Current and Historical Sales Trends6.4.7.2 Market Outlook6.4.8 Human Growth Hormones (HGH)6.4.8.1 Current and Historical Sales Trends6.4.8.2 Market Outlook6.5 Market Outlook


7 Competitive Landscape7.1 Market Breakup by Manufacturer Type7.1.1 Product Companies7.1.2 Contract Manufacturers7.2 Key Player Profiles7.2.1 Roche7.2.1.1 Company Overview7.2.1.2 Key Financials7.2.2 Amgen7.2.2.1 Company Overview7.2.2.2 Key Financials7.2.3 Novo Nordisk7.2.3.1 Company Overview7.2.3.2 Key Financials7.2.4 AbbVie7.2.4.1 Company Overview7.2.4.2 Key Financials7.2.5 Sanofi S.A7.2.5.1 Company Overview7.2.5.2 Key Financials7.2.6 Johnson & Johnson


7.2.6.1 Company Overview7.2.6.2 Key Financials7.2.7 Pfizer7.2.7.1 Company Overview7.2.7.2 Key Financials7.2.8 Merck & Co.7.2.8.1 Company Overview7.2.8.2 Key Financials7.2.9 Lilly7.2.9.1 Company Overview7.2.9.2 Key Financials7.2.10 Biogen Idec7.2.10.1 Company Overview7.2.10.2 Key Financials


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:Email: [email protected]: +91-120-415-5099

IMARC Group North America:Email: [email protected]: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:Email: [email protected]: +44-702-409-7331

To know more please visit: http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market

http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market

http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market


© 2016 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

FOR MORE DETAILSVisit us at :

Stay With Us:

TELEPHONE: +91-120-4155099 E-MAIL: [email protected]

http://www.imarcgroup.com

Contact Us

http://www.imarcgroup.com/

http://www.facebook.com/imarcgroup

http://www.linkedin.com/company/imarc-group

http://twitter.com/imarcglobal

http://plus.google.com/+imarcgroup/posts

http://www.imarcgroup.blogspot.in/





Health & Medicine

Global Biopharmaceutical Manufacturing Market Report 2016 - 2021